Compile Data Set for Download or QSAR
maximum 50k data
Found 65 Enz. Inhib. hit(s) with all data for entry = 1075
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307542(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  0.603nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307547(BDBM307549 | N-(2-(1,2,4-oxadiazol-3-yl)propan-2-y...)
Affinity DataIC50:  1.52nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307550(N-(2-cyanopropan-2-yl)-5-(6-ethoxy-2-(4-fluorophen...)
Affinity DataIC50:  1.84nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307545(6-Ethoxy-2-(4-fluorophenyl)-5-(4-methoxy-3-((1-(py...)
Affinity DataIC50:  1.89nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307566(5-(3-((2-(1,2,4-thiadiazol-3-yl)propan-2-yl)carbam...)
Affinity DataIC50:  2.04nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307561(5-(3-((2-cyanopropan-2-yl)carbamoyl)-4-(methoxy-d3...)
Affinity DataIC50:  2.04nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307542(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  2.22nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307548(N-(bicyclo[1.1.1]pentan-1-yl)-5-(6-ethoxy-2-(4-flu...)
Affinity DataIC50:  2.48nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307558(5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  2.48nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307546(5-(6-Ethoxy-2-(4-fluorophenyl)-3-(methylcarbamoyl)...)
Affinity DataIC50:  2.72nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307547(BDBM307549 | N-(2-(1,2,4-oxadiazol-3-yl)propan-2-y...)
Affinity DataIC50:  2.73nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307551(5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  2.83nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307562(5-(2-(4-Fluorophenyl)-3-(methylcarbamoyl)-6-(2,2,2...)
Affinity DataIC50:  2.95nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307543(5-(3-((2-Cyanopropan-2-yl)carbamoyl)phenyl)-2-(4-f...)
Affinity DataIC50:  3.02nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307539(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  3.31nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307537(5-(3-(Bicyclo[1.1.1]pentan-1-ylcarbamoyl)-4-fluoro...)
Affinity DataIC50:  3.88nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307567(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  3.89nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307535(2-(4-Fluorophenyl)-5-(4-methoxy-3-((1-(pyrimidin-2...)
Affinity DataIC50:  4.15nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307552(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  4.20nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307538(5-(3-(Bicyclo[1.1.1]pentan-1-ylcarbamoyl)phenyl)-6...)
Affinity DataIC50:  4.30nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307536(5-(4-Fluoro-3-((1-(pyrimidin-2-yl)cyclopropyl)carb...)
Affinity DataIC50:  4.38nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307554(5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  4.49nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307553(6-(2,2-difluoroethoxy)-2-(4-fluorophenyl)-N-methyl...)
Affinity DataIC50:  4.54nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307541(5-(3-((1-Cyanocyclopropyl)carbamoyl)phenyl)-2-(4-f...)
Affinity DataIC50:  4.97nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307539(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  5.05nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307540(6-Ethoxy-2-(4-fluorophenyl)-N-methyl-5-(3-((1-(pyr...)
Affinity DataIC50:  5.78nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307565(5-(3-((2-(3H-imidazo[4,5-c]pyridin-2-yl)propan-2-y...)
Affinity DataIC50:  6.01nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307556(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  7.14nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307534(2-(4-Fluorophenyl)-N-methyl-5-(3-((1-(pyrimidin-2-...)
Affinity DataIC50:  7.42nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307559(5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50:  30nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307557(5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataIC50: >2.50E+3nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307534(2-(4-Fluorophenyl)-N-methyl-5-(3-((1-(pyrimidin-2-...)
Affinity DataEC50:  10nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307535(2-(4-Fluorophenyl)-5-(4-methoxy-3-((1-(pyrimidin-2...)
Affinity DataEC50:  6.24nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307536(5-(4-Fluoro-3-((1-(pyrimidin-2-yl)cyclopropyl)carb...)
Affinity DataEC50:  6.70nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307537(5-(3-(Bicyclo[1.1.1]pentan-1-ylcarbamoyl)-4-fluoro...)
Affinity DataEC50:  8.61nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307538(5-(3-(Bicyclo[1.1.1]pentan-1-ylcarbamoyl)phenyl)-6...)
Affinity DataEC50:  6.5nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307539(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataEC50:  6.88nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307540(6-Ethoxy-2-(4-fluorophenyl)-N-methyl-5-(3-((1-(pyr...)
Affinity DataEC50:  10nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307541(5-(3-((1-Cyanocyclopropyl)carbamoyl)phenyl)-2-(4-f...)
Affinity DataEC50:  20nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307542(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataEC50:  1.97nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307543(5-(3-((2-Cyanopropan-2-yl)carbamoyl)phenyl)-2-(4-f...)
Affinity DataEC50:  5.01nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307544(5-(3-(Bicyclo[1.1.1]pentan-1-ylcarbamoyl)-4-methox...)
Affinity DataEC50:  9.63nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307545(6-Ethoxy-2-(4-fluorophenyl)-5-(4-methoxy-3-((1-(py...)
Affinity DataEC50:  4.20nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307546(5-(6-Ethoxy-2-(4-fluorophenyl)-3-(methylcarbamoyl)...)
Affinity DataEC50:  3.67nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307547(BDBM307549 | N-(2-(1,2,4-oxadiazol-3-yl)propan-2-y...)
Affinity DataEC50:  3.20nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307548(N-(bicyclo[1.1.1]pentan-1-yl)-5-(6-ethoxy-2-(4-flu...)
Affinity DataEC50:  7.03nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307547(BDBM307549 | N-(2-(1,2,4-oxadiazol-3-yl)propan-2-y...)
Affinity DataEC50:  2.95nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307550(N-(2-cyanopropan-2-yl)-5-(6-ethoxy-2-(4-fluorophen...)
Affinity DataEC50:  2.80nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307551(5-(3-((2-(1,2,4-oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataEC50:  2.85nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGenome polyprotein(Hepatitis C virus (HCV))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM307552(5-(3-((2-(1,2,4-Oxadiazol-3-yl)propan-2-yl)carbamo...)
Affinity DataEC50:  7.41nMAssay Description:To evaluate compound efficacy, titrated compounds were transferred to sterile 384-well tissue culture treated plates, and the plates were seeded with...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 65 total ) | Next | Last >>
Jump to: